Czechia, Dec. 15 -- Czechia based VIVAX Management (CZ), s.r.o. has secured contract from Fakultni nemocnice Hradec Kralove for Pituitary, hypothalamic hormones and analogues - Medicinal preparations containing octreotide, lanreotide and pasireotide. The value of the contract is worth 781833110 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....